Evogene (EVGN) Q2 2026 Earnings

20MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.63
-0.27
0.09
0.44

Details

Expected EPS
-0.27
Actual EPS
-0.6
Surprise EPS
-0.33
Surprise Percent
+122.22%

Description

Evogene (EVGN) has reported earnings of -0.6 per share for Q2 2026.

0 Comments

Share your thoughts